Skip to main content
Log in

The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusions

  • ORIGINAL ARTICLE
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

 We assumed that a recovery of thrombopoiesis after intensive chemotherapy for acute myelogenous leukemia (AML) could reduce the need for prophylactic platelet transfusions. We therefore assessed the start of platelet production by means of daily determination of reticulated platelets (RP). The increase in RP occurred on day 20 (median) after the start of chemotherapy and was followed by a rise of peripheral platelet counts 2–3 days thereafter. Consequently, a rise of RP during the period of recovery can be regarded as representing the reconstitution of the peripheral platelet count and may reduce or eliminate the need for prophylactic platelet transfusions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: December 10, 1998 / Accepted: March 3, 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stohlawetz, P., Stiegler, G., Höcker, P. et al. The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusions. Ann Hematol 78, 271–273 (1999). https://doi.org/10.1007/s002770050513

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002770050513

Navigation